Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats

Clinical and Experimental Immunology

Volumn 114, Issue 3, 1998, Pages 477-484

  Carlsen S ^a   Hansson, A S ^a   Olsson, H ^a   Heinegard D ^a   Holmdahl, R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Cartilage; Experimental animal models; MHC; Rheumatoid arthritis

Indexed keywords

MATRIX PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CARTILAGE; CHONDROLYSIS; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; RATS;

EID: 0031792968     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00739.x     Document Type: Article

References (38)

1. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205-13.
2. Clague RB, Moore LJ. IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid. Arthritis Rheum 1984; 27:1370-7.
3. Rowley MJ, Williamson DJ, Mackay IR. Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthritis Rheum 1987; 30:1420-5.
4. Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32:1087-92.
5. Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum 1996; 39:1720-7.
6. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977; 146:857-68.
7. Holmdahl R, Vingsbo C, Hedrich H, Karlsson M, Kvick C, Goldschmidt TJ, Gustafsson K. Homologous collagen-induced arthritis in rats and mice are associated with structurally different major histocompatibility complex DQ-like molecules. Eur J Immunol 1992; 22:419-24.
8. Morgan K, Evans HB, Firth SA, Smith MN, Ayad S, Weiss JB, Holt PJL. 1a,2a,3a collagen is arthritogenic. Ann Rheum Dis 1983; 42:680-3.
9. Cremer MA, Griffiths MM, Terato K, Kang AH, Type XI and II collagen-induced arthritis in rats: characterization of inbred strains of rats for arthritis-susceptibility and immune-responsiveness to type XI and II collagen. Autoimmunity 1995; 20:153-61.
10. Boissier MC, Chiocchia G, Ronziere MC, Herbage D, Fournier C. Arthritogenicity of minor cartilage collagens (types IX and XI) in mice. Arthritis Rheum 1990; 33:1-8.
11. Giant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in Balb/c mice. Arthritis Rheum 1987; 30:201-12.
12. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990; 118:193-232.
13. Hedbom E, Antonsson P, Hjerpe A et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992; 267:6132-6.
14. Mörgelin M, Heinegård D, Engel J, Paulsson M. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem 1992; 267:6137-41.
15. Oldberg A, Antonsson P, Lindblom K, Heinegård D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992; 267:22346-50.
16. Shen Z, Heinegård D, Sommarin Y. Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biol 1995; 14:773-81.
17. Fife RS. Identification of cartilage matrix glycoprotein in synovial fluid in human osteoarthritis. Arthritis Rheum 1988; 31:553-6.
18. Nguyen BQ, Fife RS. Vitreous contains a cartilage-related protein. Exp Eye Res 1986; 43:375-82.
19. DiCesare P, Hauser N, Lehman D, Pasumarti S, Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Letters 1994; 354:237-40.
20. Smith R, Zunino L, Webbon P, Heinegård D. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 1997; 16:255-71.
21. Di Cesare PE, Carlson CS, Stollerman ES, Chen FS, Leslie M, Perris R. Expression of cartilage oligomeric matrix protein by human synovium. FEBS Letters 1997; 412:249-52.
22. Briggs MD, Hoffman SM, King LM et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 1995; 10:330-6.
23. Saxne T, Heinegård D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992; 31:583-91.
24. Vingsbo-Lundberg C, Saxne T, Olsson H, Holmdahl R. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum 1998; 41:544-50.
25. Goldschmidt TJ, Holmdahl R. Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis. Suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 1991; 21:1327-30.
26. Vingsbo C, Larsson P, Andersson M, Holmdahl R. Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats. Scand J Immunol 1993; 37:337-42.
27. Holmdahl R, Vingsbo C, Malmstrom V, Jansson L, Holmdahl M. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is dependent on anti-CII B-cell activation. J Autoimmun 1994; 7:739-52.
28. Holmdahl R, Goldschmidt TJ, Kleinau S, Kvick C, Jonsson R. Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 1992; 76:197-202
29. Vingsbo C, Jonsson R, Holmdahl R. Avridine-induced arthritis in rats: a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 1995; 99:354-63.
30. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompalibility complex genes. Am J Pathol 1996; 149:1675-83.
31. Kjellén P, Issazadeh S, Olsson T, Holmdahl R. Genetic influence on disease course and cytokine response in relapsing experimental allergic encephalomyelitis, Int Immunol 1998; 10:333-40.
32. Holmdahl R, Kvick C. Vaccination and genetic experiments demonstrate that adjuvant oil induced arthritis and homologous type II collagen induced arthritis in the same rat strain are different diseases. Clin Exp Immunol 1992; 88:96-100.
33. Holmdahl R, Jonsson R, Larsson P, Klareskog L. Early appearance of activated CD4 positive T lymphocytes and Ia-expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab Invest 1988; 58:53-60.
34. Holmdahl R, Carlsén S, Mikulowska A et al. Genetic analysis of murine models for rheumatoid arthritis. In: Adolpho K, ed. Human genome methods. Boca Raton/New York: CRC Press, 1998:215-38.
35. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. 1. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 1991; 4:871-80.
36. Lorentzen JC, Klareskog L. Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex. Scand J Immunol 1996; 44:592-8.
37. Liu GY, Wraith DC. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice-implications for autoimmunity. Int Immunol 1995; 7:1255-63.
38. Erlandsson-Harris H. Studies of the immunopathogensis in three arthritis models in rats. Stockholm: Karoliska Institute, Dept of Medicine, 1997.